Skip Navigation

This Article
Right arrow Print PDF (1531K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Kobayashi, T.
Right arrow Articles by Hino, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobayashi, T.
Right arrow Articles by Hino, O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1995, Vol. 23, No. 14 2608-2613
© 1995


MOLECULAR BIOLOGY

cDNA structure, alternative splicing and exon—intron organization of the predisposing tuberous scelerosis (Tsc2) gene of the Eker rat model

Toshiyuki Kobayashi, Masae Nishizawa, Youko Hirayama, Etsuko Kobayashi and Okio Hino*

Department of Experimental Pathology, Cancer Institute 1–37–1 Kami-ikebukuro, Toshima-ku, Tokyo 170, Japan

*To whom correspondence should be addressed

Received May 3, 1995. Accepted June 12, 1995.

The Eker rat hereditary renal carcinoma (RC) is an excellent example of a Mendellan dominant predisposition to a specific cancer in an experimental animal. We recently reported that a germline insertion In the rat homologue of the human tuberous sclerosis gene (TSC2) gives rise to the dominantly inherited cancer in the Eker rat model. We now describe the entire cDNA (5375 bp without exons 25 and 31) and genomlc structure of the rat Tsc2 gene. The deduced amlno acid sequence (1743 amino acids) shows 92% identity to the human counterpart Surprisingly, there are a great many (>41) coding exons with small sized Introns spanning only –35 kb of genomlc DNA. Two alternative splicing events [involving exons 25 (129 bp) and 31 (69 bp)] make for a complex diversity of the Tsc2 product. The present determination of the Tsc2 gene and establishment of strong conservation between the rat and man provide clues for assessing unknown gene functions apart from that already predicted from the GTPase activating proteins (GAP3) homologous domain and for future analysis of intragenic mutations in tumors using methods such as PCR-SSCP and for insights into diverse phenotypes between species.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
S. Momose, T. Kobayashi, H. Mitani, M. Hirabayashi, K. Ito, M. Ueda, Y.-i. Nabeshima, and O. Hino
Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system
Hum. Mol. Genet., November 15, 2002; 11(24): 2997 - 3006.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Goncharova, D. A. Goncharov, A. Eszterhas, D. S. Hunter, M. K. Glassberg, R. S. Yeung, C. L. Walker, D. Noonan, D. J. Kwiatkowski, M. M. Chou, et al.
Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation. A ROLE FOR THE TSC2 TUMOR SUPPRESSOR GENE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS (LAM)
J. Biol. Chem., August 16, 2002; 277(34): 30958 - 30967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H.-S. Yoon, T. J. Monks, J. I. Everitt, C. L. Walker, and S. S. Lau
Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity
Am J Physiol Renal Physiol, August 1, 2002; 283(2): F262 - F270.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D.C. Wolf, T.L. Goldsworthy, D.B. Janszen, R. Harden, E.M. Donner, C.S. David, and J.I. Everitt
Promotion by sodium barbital induces early development but does not increase the multiplicity of hereditary renal tumors in Eker rats
Carcinogenesis, August 1, 2000; 21(8): 1553 - 1558.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. B. S. Pasumarthi, H. Nakajima, H. O. Nakajima, S. Jing, and L. J. Field
Enhanced Cardiomyocyte DNA Synthesis During Myocardial Hypertrophy in Mice Expressing a Modified TSC2 Transgene
Circ. Res., May 26, 2000; 86(10): 1069 - 1077.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Kobayashi, O. Minowa, J. Kuno, H. Mitani, O. Hino, and T. Noda
Renal Carcinogenesis, Hepatic Hemangiomatosis, and Embryonic Lethality Caused by a Germ-Line Tsc2 Mutation in Mice
Cancer Res., March 1, 1999; 59(6): 1206 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Satake, T. Kobayashi, E. Kobayashi, K. Izumi, and O. Hino
Isolation and Characterization of a Rat Homologue of the Human Tuberous Sclerosis 1 Gene (Tsc1) and Analysis of Its Mutations in RatRenal Carcinomas
Cancer Res., February 1, 1999; 59(4): 849 - 855.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Kobayashi, H. Mitani, R.-i. Takahashi, M. Hirabayashi, M. Ueda, H. Tamura, and O. Hino
Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene
PNAS, April 15, 1997; 94(8): 3990 - 3993.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.